Literature DB >> 33437388

Methyl-CpG-binding domain 3 (Mbd3) is an important regulator for apoptosis in mouse embryonic stem cells.

Yujian Dai1, Jinshan Li1, Mingyang Li1, Zhihui Liu1, Jiao Liu1, Liyou An1, Fuliang Du1,2.   

Abstract

Methyl-CpG-binding domain 3 (Mbd3) is a core repressor complex component. Although Mbd3 is required for the pluripotency of embryonic stem cells (ES), the role of Mbd3 in mouse ES (mES) cell apoptosis remains undefined. In this study naïve-state mES were derived and maintained in the presence of a selective protein kinase C pathway inhibitor (PKCi; Gӧ6983) to study the function of Mbd3 during mES apoptosis. Mbd3 overexpression in mES decreased the total cell number and viability, and it also dramatically increased the rate of apoptosis. Further investigation of Mbd3 overexpression revealed a 3-fold increase in the proapoptotic/prosurvival protein ratio (Bax/Bcl-2) and elevated RNA expression levels of apoptosis-related genes, including Bim, Trail, Fasl, and caspase 3, with reduced Bcl-2 RNA expression levels. Removal of PKCi from the mES cell culture resulted in upregulated Mbd3 expression and apoptosis, similar to the effects of Mbd3 overexpression. Furthermore, specific knockdown of endogenous Mbd3 partially rescued the mES apoptosis induced by the removal of PKCi, thus increasing the total cell number and viability while decreasing the rate of apoptosis. Additionally, Bax, Bim, Trail, and caspase 3 RNA expression levels were partially reduced, and that of Bcl-2 was partially increased. Our findings support Mbd3 as a pivotal regulator of apoptosis in mES. AJTR
Copyright © 2020.

Entities:  

Keywords:  Mbd3; Mouse embryonic stem cells; PKC inhibitor; cell apoptosis; protein kinase C

Year:  2020        PMID: 33437388      PMCID: PMC7791517     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  46 in total

1.  Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways.

Authors:  A Suliman; A Lam; R Datta; R K Srivastava
Journal:  Oncogene       Date:  2001-04-19       Impact factor: 9.867

Review 2.  Apoptosis: a review of programmed cell death.

Authors:  Susan Elmore
Journal:  Toxicol Pathol       Date:  2007-06       Impact factor: 1.902

Review 3.  Signal transduction during apoptosis; implications for cancer therapy.

Authors:  M Story; R Kodym
Journal:  Front Biosci       Date:  1998-03-23

Review 4.  Protein kinase C and lipid signaling for sustained cellular responses.

Authors:  Y Nishizuka
Journal:  FASEB J       Date:  1995-04       Impact factor: 5.191

5.  Characterization of 8p21.3 chromosomal deletions in B-cell lymphoma: TRAIL-R1 and TRAIL-R2 as candidate dosage-dependent tumor suppressor genes.

Authors:  Fanny Rubio-Moscardo; David Blesa; Cinta Mestre; Reiner Siebert; Theo Balasas; Adalberto Benito; Andreas Rosenwald; Joan Climent; Jose I Martinez; Markus Schilhabel; E Lorraine Karran; Stefan Gesk; Manel Esteller; Ronald deLeeuw; Louis M Staudt; Jose Luis Fernandez-Luna; Daniel Pinkel; Martin J S Dyer; Jose A Martinez-Climent
Journal:  Blood       Date:  2005-07-28       Impact factor: 22.113

6.  Overexpression of BCL2 enhances survival of human embryonic stem cells during stress and obviates the requirement for serum factors.

Authors:  Reza Ardehali; Matthew A Inlay; Shah R Ali; Chad Tang; Micha Drukker; Irving L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-07       Impact factor: 11.205

7.  Identification and characterization of a family of mammalian methyl-CpG binding proteins.

Authors:  B Hendrich; A Bird
Journal:  Mol Cell Biol       Date:  1998-11       Impact factor: 4.272

8.  The ground state of embryonic stem cell self-renewal.

Authors:  Qi-Long Ying; Jason Wray; Jennifer Nichols; Laura Batlle-Morera; Bradley Doble; James Woodgett; Philip Cohen; Austin Smith
Journal:  Nature       Date:  2008-05-22       Impact factor: 49.962

9.  Human embryonic stem cells express elevated levels of multiple pro-apoptotic BCL-2 family members.

Authors:  David T Madden; Diana Davila-Kruger; Simon Melov; Dale E Bredesen
Journal:  PLoS One       Date:  2011-12-09       Impact factor: 3.240

10.  NuRD suppresses pluripotency gene expression to promote transcriptional heterogeneity and lineage commitment.

Authors:  Nicola Reynolds; Paulina Latos; Antony Hynes-Allen; Remco Loos; Donna Leaford; Aoife O'Shaughnessy; Olukunbi Mosaku; Jason Signolet; Philip Brennecke; Tüzer Kalkan; Ita Costello; Peter Humphreys; William Mansfield; Kentaro Nakagawa; John Strouboulis; Axel Behrens; Paul Bertone; Brian Hendrich
Journal:  Cell Stem Cell       Date:  2012-05-04       Impact factor: 24.633

View more
  3 in total

1.  PKC inhibitors regulate stem cell self-renewal by regulating H3K27me3 and H3K9me3.

Authors:  Jialei Sun; Na He; Weiguo Wang; Yujian Dai; Chunhui Hou; Fuliang Du
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

Review 2.  Regulation of Developmental Cell Death in the Animal Kingdom: A Critical Analysis of Epigenetic versus Genetic Factors.

Authors:  Juan A Montero; Carlos Ignacio Lorda-Diez; Juan M Hurle
Journal:  Int J Mol Sci       Date:  2022-01-21       Impact factor: 5.923

3.  Nucleosome remodeling and deacetylation complex and MBD3 influence mouse embryonic stem cell naïve pluripotency under inhibition of protein kinase C.

Authors:  Yujian Dai; Jialei Sun; Na He; Liyou An; Chunhui Hou; Fuliang Du
Journal:  Cell Death Discov       Date:  2022-08-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.